Richard Edward Turner

Title: Richard Edward Turner: Innovator in Polypeptide Purification

Introduction

Richard Edward Turner is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the purification of recombinantly produced polypeptides. His innovative methods have the potential to enhance the efficiency of protein purification processes.

Latest Patents

Turner holds a patent for the "Purification of recombinantly produced polypeptides." This patent describes a method for separating a recombinantly produced polypeptide from host cell protein. The process involves loading a clarified cell culture supernatant containing the polypeptide and host cell proteins onto a Protein A chromatography column. The column is then washed with a specific wash buffer that includes a fatty acid with a chain length of at least six carbon atoms, or a fatty acid salt, to effectively remove host cell proteins. Finally, the recombinantly produced polypeptide is recovered, showcasing a novel approach to protein purification.

Career Highlights

Richard Edward Turner is associated with Medimmune Limited, where he applies his expertise in biotechnology and protein purification. His work at Medimmune has allowed him to contribute to advancements in the field, particularly in the development of therapeutic proteins.

Collaborations

Turner has collaborated with notable colleagues, including Christopher Douglas Afdahl and David Edwin Gruber. These collaborations have likely fostered an environment of innovation and shared knowledge, further enhancing the impact of their work in biotechnology.

Conclusion

Richard Edward Turner is a distinguished inventor whose work in the purification of recombinantly produced polypeptides has made a significant impact in biotechnology. His innovative methods and collaborations continue to advance the field, demonstrating the importance of research and development in creating effective biotechnological solutions.